As one of the causes of cardiovascular disease, eNOS can be observed in cardiomyocytes, where empagliflozin treatment triggers eNOS phosphorylation, confirming its cardioprotective abilities (104). The gene discussed is NOS3; the disease is cardiovascular disorder.